Skip to main content
OpenTrials
Completed

NCT Number: NCT01881672

Syndrome and Aspiration Pneumonia in Intensive Care

Inhalation is a common condition in patients with impaired their awareness requiring protection of the upper airway by endotracheal intubation. This inhalation may lead to chemical pneumonitis and/or bacterial pneumonia. Only the latter requires the administration of antibiotics. Patients developing such a bacterial pneumonia, has a mortality, duration of mechanical ventilation and length of ICU stay increased. However, the proportion of patients with such bacterial pneumonia, bacterial ecology and morbidity that are little known.

The aim of this study is to determine the frequency of bacterial pneumonia in patients admitted to the ICU for coma and treated with mechanical ventilation

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Altered consciousness defined by a Glasgow Coma Scale score less than or equal to 8 before protection of the upper airway by endotracheal intubation
  • Patient under mechanical ventilation

Exclusion criteria

  • Patient with pre-existing impairment of laryngeal function in Parkinson's disease, Alzheimer's disease, amyotrophic lateral sclerosis, laryngeal cancer, radiotherapy laryngeal
  • Patient under guardianship
  • Inpatient without consent
  • Pregnant woman
  • Patient previously treated with antibiotics for more than 24 hours at the time of ICU admission
  • Patient with infection at ICU admission which justified probabilist antibiotic treatment
  • Lack of social security
  • Refusal of the patient or their next of kind

Treatment and study plan

Primary outcomes

  1. Determine the frequency of bacterial pneumonia in patients admitted to the ICU for coma and treated with mechanical ventilation

    Time frame: ICU Discharge

    Participants will be followed for the duration of ICU stay, an expected average of 4 days

Secondary outcomes

  1. Quantify the use of antibiotics during the ICU stay for patients admitted to the ICU for coma and treated with mechanical ventilation

    Time frame: ICU Discharge

    Participants will be followed for the duration of ICU stay, an expected average of 4 days

  2. Description of the bacterial flora identified in respiratory specimens.

    Time frame: ICU Discharge

    Participants will be followed for the duration of ICU stay, an expected average of 4 days

  3. Identification of predictive factors for development of bacterial pneumonia

    Time frame: ICU Discharge

    Participants will be followed for the duration of ICU stay, an expected average of 4 days

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Departemental Vendee

Other

Registry information

Acronym: SPIRE

Important dates

Study start
2012
Primary completion
2015
Study completion
2015
First posted
Jun 20, 2013
Registry last updated
Aug 26, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.